Abstract:Abstract:The title compound (2) was prepared in high yield by catalytic transfer hydrogenation of the 6-nitro precursor (1), using hydrazine hydrate as the hydrogen source. Under the conditions employed, the ester groups remain unaffected. The new compound was fully characterised by elemental analysis, . Such compounds are known to act as topoisomerase II poisons and as another common structural feature they possess a heteroaromatic ring fused to the carbazole 2,3-bond. Typically, this is a pyridine unit (like… Show more
“…With the 2-nitro compound 4a [ 16 ] and the new 4-nitro isomer 4b in hands, preparation of the corresponding two amino-substituted Luotonin A derivatives should be feasible in a straightforward manner by reduction of the NO 2 group. While Cagir et al [ 20 ] had obtained 8-amino-Luotonin A from the 8-nitro precursor by reduction with SnCl 2 in moderate yield (40%) and Dallavalle et al [ 25 ] had reported an unsuccessful attempt to selectively reduce the nitro group in 9-nitro-Luotinin A by catalytic hydrogenation in acetic acid, we decided to apply a protocol that had been successfully used for the reduction of nitrocarbazoles into aminocarbazoles [ 26 , 27 ]. This method makes use of hydrazine hydrate as hydrogen source in a catalytic transfer hydrogenation reaction in alcoholic solution or suspension at elevated temperature.…”
Following two orthogonal synthetic routes, a series of all four possible A-ring amino derivatives of the natural product Luotonin A (a known Topoisomerase I inhibitor) was synthesized. In both strategies, intramolecular cycloaddition reactions are the key step. The target compounds were obtained in good yields by mild catalytic transfer hydrogenation of the corresponding nitro precursors. In-vitro evaluation of the antiproliferative activity towards human tumor cell lines revealed the 4-amino compound (5b) to be the most effective agent, showing an interesting profile of cytotoxic activity. Among other effects, a significant G2/M cell cycle arrest was observed for this compound, suggesting that either Topoisomerase I is not the only biological target, or that some atypical mechanism is responsible for inhibition of this enzyme.
“…With the 2-nitro compound 4a [ 16 ] and the new 4-nitro isomer 4b in hands, preparation of the corresponding two amino-substituted Luotonin A derivatives should be feasible in a straightforward manner by reduction of the NO 2 group. While Cagir et al [ 20 ] had obtained 8-amino-Luotonin A from the 8-nitro precursor by reduction with SnCl 2 in moderate yield (40%) and Dallavalle et al [ 25 ] had reported an unsuccessful attempt to selectively reduce the nitro group in 9-nitro-Luotinin A by catalytic hydrogenation in acetic acid, we decided to apply a protocol that had been successfully used for the reduction of nitrocarbazoles into aminocarbazoles [ 26 , 27 ]. This method makes use of hydrazine hydrate as hydrogen source in a catalytic transfer hydrogenation reaction in alcoholic solution or suspension at elevated temperature.…”
Following two orthogonal synthetic routes, a series of all four possible A-ring amino derivatives of the natural product Luotonin A (a known Topoisomerase I inhibitor) was synthesized. In both strategies, intramolecular cycloaddition reactions are the key step. The target compounds were obtained in good yields by mild catalytic transfer hydrogenation of the corresponding nitro precursors. In-vitro evaluation of the antiproliferative activity towards human tumor cell lines revealed the 4-amino compound (5b) to be the most effective agent, showing an interesting profile of cytotoxic activity. Among other effects, a significant G2/M cell cycle arrest was observed for this compound, suggesting that either Topoisomerase I is not the only biological target, or that some atypical mechanism is responsible for inhibition of this enzyme.
“…Replacement of gaseous hydrogen with liquid or solid hydrogen sources in catalytic hydrogenation reactions is generally referred to as catalytic transfer hydrogenation [13] and it offers some advantages in terms of safety, as well as easier reaction monitoring and (in some cases) easier work-up. We previously made positive experiences with the selective reduction of a nitrocarbazolediester by catalytic transfer hydrogenation [14], employing Deady's protocol [15]. Recently, we successfully employed this technique also to the synthesis of A-ring amino derivatives of Luotonin A [4].…”
Chemoselective reduction of the corresponding 9-nitro precursor by catalytic transfer hydrogenation afforded the title compound, a new 9-amino derivative of the antitumor alkaloid Luotonin A, in good yield. The structure of the compound was established by means of 1D and 2D 1H-NMR and 13C-NMR spectroscopy as well as by EI-MS and high-resolution ESI-MS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.